Approaching two years in her position as GSK’s Vice President and General Manager for the Gulf region, Gizem Akalin, PhD, outlines the tremendous growth potential of…
In Conversation
Europe is instrumental to the evolution that Medtronic is undergoing. Many strategic initiatives in the recent past have been piloted on this continent.
Greater anticipation would allow patients’ faster access to innovation but requires a lot more collaborative work and dialogue between the industry, regulators, and payers ...
Our Italian companies are very important for the B. Braun Group, since Italy is one of the top ten countries by third-party sales in the group…
EIPICO will become the first company in the MENA region to produce biological products starting from the cell line all the way through upstream, downstream, formulation…
The healthcare industry in the GCC has evolved drastically over the past few years and our medical equipment and IT business has also changed—from quantity to…
... inflammatory skin disease is a highly promising area for the company because we have a lot of knowledge about the skin. However, we found that…
Both the Spanish healthcare system and its healthcare professionals are strongly recognised worldwide, which has opened great opportunities in R&D and clinical trials for new treatments…
I want to give a lot of credit to the Italian institutions for an open dialogue in solving many different issues together under tight timelines and…
STADA has changed a lot in the last three or four years ... One aspect of that change is growth, but more importantly, how we achieve…
I was lucky to have a front row seat in the transformation of what was a small, primary care-focused Italian company into an internatonal biotech.
Our expectations for 2022 are mainly related to the launches of our products, including a drug for epilepsy and another for psoriasis; it is a year…
